Ampreloxetine

N/A

Report date: 2024/03/28 17:43:57
NME

Base Information

Drug NameAmpreloxetine
Drug Alias NameTD-9855
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDrug-Related Side Effects and Adverse ReactionsParkinson Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheravance Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHypotension, OrthostaticMultiple System Atrophy
Inactive IndicationsAttention Deficit Disorder with HyperactivityDrug-Related Side Effects and Adverse ReactionsParkinson Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A